Phillip P. Chan
2021
In 2021, Phillip P. Chan earned a total compensation of $1.8M as Chief Executive Officer at Cytosorbents, a 29% increase compared to previous year.
Compensation breakdown
| Bonus | $172,619 |
|---|---|
| Option Awards | $475,846 |
| Salary | $482,851 |
| Stock Awards | $647,280 |
| Other | $12,000 |
| Total | $1,790,596 |
Chan received $647.3K in stock awards, accounting for 36% of the total pay in 2021.
Chan also received $172.6K in bonus, $475.8K in option awards, $482.9K in salary and $12K in other compensation.
Rankings
In 2021, Phillip P. Chan's compensation ranked 6,475th out of 12,415 executives tracked by ExecPay. In other words, Chan earned more than 47.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,475 out of 12,415 | 48th |
Division Manufacturing | 2,774 out of 5,508 | 50th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 359 out of 801 | 55th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 224 out of 522 | 57th |
Industry Surgical and Medical Instruments and Apparatus | 144 out of 327 | 56th |
Source: SEC filing on April 22, 2022.
Chan's colleagues
We found three more compensation records of executives who worked with Phillip P. Chan at Cytosorbents in 2021.